Godsey & Gibb Associates Astrazeneca PLC Transaction History
Godsey & Gibb Associates
- $995 Million
- Q1 2025
A detailed history of Godsey & Gibb Associates transactions in Astrazeneca PLC stock. As of the latest transaction made, Godsey & Gibb Associates holds 166 shares of AZN stock, worth $11,219. This represents 0.0% of its overall portfolio holdings.
Number of Shares
166
Previous 49
238.78%
Holding current value
$11,219
Previous $3,000
300.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding AZN
# of Institutions
1,380Shares Held
476MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.08 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$2.77 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.54 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.62 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.32 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $209B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...